Research Solutions: No Antibodies Available

No Specific Antibody? No Problem.

It is known that over 70% of protein-coding genes have no reliable antibody available for immunohistochemistry (IHC). Often, the wait for new antibodies to be developed results in a longer-than expected project timeline.  By using our RNAscope™ in situ hybridization assays; with rapid probe design and universal assay workflows for any gene, you can bypass the frustrations of antibody screening, saving you precious time and effort, while also delivering publication quality data.

Now you can detect ANY RNA.

With RNAscope™ in situ hybridization technology, you can now detect virtually any gene, in any species, including non-coding RNA. The rapid probe design and universal assay workflows for any gene, saves you time and effort, while delivering publication-quality data. The single-molecule detection sensitivity of RNAscope™ in situ hybridization enables you to target low-expressing genes and even non-coding RNA, opening your research to new possibilities.

Why wait for an antibody?

Don’t let your research project becme delayed while you wait for new antibodies to be developed. Start your biomarker validation now with RNAscope™ in situ hybridization technology. With rapid probe design and universal assay workflows for any gene, the RNAscope™ assays save essential time and resources while accelerating the companion diagnostic test development process.

No more antibody requirements.

Our specifically targeted RNAscope™ in situ hybridization products and services deliver the results you need in a timely manner. Whether your target is a novel gene with no commercial antibody available, a secreted protein with poor-quality antibodies for IHC, or a non-coding RNA, we can provide data with single-molecule detection sensitivity, utilizing our award-winning RNAscope™ Technology.

It’s easy to start YOUR assay.

• Free yourself from the lengthy process of antibody screening.
• Get high quality, publication-ready data now.
• Present superior results while optimizing time, tissue and resources.